EYLEA®
Brand Name: EYLEA®
Composition: Aflibercept Injection 40 ml solution for intravitreal use)
Product Description
Medical Info
EYLEA® is a highly specialized prescription biologic containing Aflibercept (40 mg/ml), manufactured through a partnership involving Bayer Zydus Pharma. Formulated explicitly as a solution for intravitreal injection, it is administered directly into the eye by a trained ophthalmologist to treat advanced retinal conditions like wet age-related macular degeneration. Each carton contains a single-use sterile vial intended strictly for a individual dose to maintain maximum ocular safety. By inhibiting vascular endothelial growth factors, this targeted therapeutic intervention helps reduce abnormal blood vessel growth and fluid leakage in the retina, preserving critical vision for patients.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
